Sign in

Colorectal cancer

Current status: Treatable, not yet curable

A cancer that starts in the colon or the rectum, parts of the large bowel. Signs include blood in your poo, changes in your usual bowel habits, tummy pain and losing weight without trying. Surgery is the most common treatment for colon cancer. You may also have chemotherapy, radiotherapy, targeted medicines or immunotherapy. The risk grows with age, and screening tests from about 45 can help find it early, when it may be easier to treat.

Read more about colorectal cancer
Where research stands todayUpdated 18 Nov 2026

Trial-stage treatments and research studies you can joinOpen trials for referral

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsPortugal, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Trial-stage treatmentPhase 2Soon in Portugal
    Tests VVD-133214 with pembrolizumab in advanced colorectal cancer

    Tests VVD-133214 plus pembrolizumab in adults with advanced colorectal cancer with MSI or dMMR.

    Coimbra, PortugalAlso Lisbon, PortoAge 18+
  2. Trial-stage treatmentPhase 1/2Taking people
    EIK1005 alone or with pembrolizumab for advanced solid tumors

    Tests EIK1005, alone and with pembrolizumab, in adults with advanced solid tumors.

    Lisbon, PortugalAlso Loures, PortoAge 18+
  3. Trial-stage treatmentPhase 1/2Taking people
    Tests ifinatamab deruxtecan in several types of recurrent or spreading solid tumors

    Tests ifinatamab deruxtecan in adults with solid tumors that returned or spread.

    Lisbon, PortugalAlso PortoAge 18+
  4. Trial-stage treatmentPhase 3Taking people
    Tests telisotuzumab adizutecan with bevacizumab in colorectal cancer that stopped responding

    Compares a new drug with bevacizumab against standard treatment in adults with colorectal cancer.

    Almada, PortugalAlso Guimaraes, Lisbon, PortoAge 18+
  5. Trial-stage treatmentPhase 3Taking people
    Tests sotorasib with panitumumab and FOLFIRI in colorectal cancer

    Compares sotorasib combination treatment with FOLFIRI in adults with KRAS-mutated colorectal cancer.

    Almada, PortugalAlso Coimbra, Lisbon, Matosinhos Municipality, Santa Maria da FeiraAge 18+
  6. Trial-stage treatmentPhase 3
    Tests dostarlimab before and after surgery for certain colon cancers

    Tests dostarlimab with surgery in adults with resectable colon cancer.

    Almada, PortugalAlso CoimbraAge 18+
  7. Trial-stage treatmentPhase 3Taking people
    Chemotherapy before chemoradiotherapy and surgery for recurrent rectal cancer

    Tests chemotherapy given before chemoradiotherapy and surgery in adults with returned rectal cancer.

    Lisbon, PortugalAge 18+
  8. Research studyTaking people
    Studying new tests to detect colon cancer early in people at high risk

    Studies new low-cost tests for colon cancer detection in high-risk adults across Europe.

    Porto, PortugalAge 18+
  9. Trial-stage treatmentPhase 1Soon in Portugal
    Tests a radioactive drug and a scan agent in adults with advanced solid tumors

    Tests a radioactive drug and a scan agent in adults with advanced cancers.

    Porto, PortugalAge 18+
  10. Trial-stage treatmentPhase 3Taking people
    Tests sotorasib with chemotherapy in adults with colorectal cancer carrying a KRAS G12C mutation

    Tests sotorasib with chemotherapy in adults with metastatic colorectal cancer carrying KRAS G12C.

    Almada, PortugalAlso Coimbra, LisbonAge 18 to 64
  11. Research studyTaking people
    Looking for gut microbe markers in stool to aid early bowel cancer screening

    Studies gut bacteria in stool samples to find markers of bowel cancer and polyps.

    Lisbon, PortugalAge 40 to 74
  12. Research studyTaking people
    Studies gut bacteria as clues to colorectal cancer in adults

    Observes gut microbiome samples in people with colorectal cancer, including early-onset cases.

    Lisbon, PortugalAge 40 to 74
  13. Trial-stage treatmentSoon in Portugal
    Asks Healthy Adults About Preferred Colorectal Cancer Screening Methods

    Asks adults aged 50 to 69 without symptoms about their screening experience and preferences.

    Lisbon, PortugalAge 50 to 69
  14. Trial-stage treatmentTaking people
    Tests reminder messages and calls to boost colorectal cancer screening uptake

    Tests text message and phone reminders in people aged 49 to 75 for colorectal cancer.

    Porto, PortugalAge 49 to 75
  15. Trial-stage treatmentSoon in Portugal
    PreveCol blood test for finding colorectal cancer after a positive stool test

    Tests the PreveCol blood test for colorectal cancer in people with positive stool results.

    Lisbon, PortugalAge 50 to 69

Search the publications

The results open on the publications page in a new tab, so this page stays as it is.

Lists with this disease filtered

Where treatment stands

In the EU, fruquintinib got its first authorisation in June 2024.

Approved: 26

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 64

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 5

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Lab research stage: 2

Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.

Support organisations

Patient organisations and helplines in Portugal, for you and your family.

Colorectal cancer organisations in Portugal

  • Europacolon Portugal – Associação de Luta Contra o Cancro do Intestino

    Portuguese association supporting patients with digestive cancers, with information on colon health, prevention, early diagnosis and treatment.

General support in Portugal

  • SOS Voz Amiga

    Portuguese confidential emotional support helpline for people experiencing loneliness, anxiety, depression or suicidal thoughts.

  • ERS – Entidade Reguladora da Saúde

    Portugal's independent public health regulator, which safeguards patients' rights of access and handles complaints about healthcare providers.

  • SNS 24

    Digital front desk and 24/7 phone line (808 24 24 24) of Portugal's National Health Service for health information, triage and services.

Frontlight Community

Colorectal cancer community in Portugal

People living with colorectal cancer and those close to them share what they went through. Posts are not medical advice: ask your doctor about your own treatment.

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

26 medicines are approved for colorectal cancer in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Checked on 18 Nov 2026 in the official lists of the US (FDA), the EU (European Commission and EMA) and Switzerland (Swissmedic), which we read every day. The lists of Japan (PMDA, approvals since April 2004), France (ANSM, medicines approved in France only) and Taiwan (TFDA) were checked on 11 Nov 2026. For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. The French ratings are the opinions of the HAS Transparency Committee, from the French public medicines database (base de données publique des médicaments, newest opinion 10 Dec 2025). 11 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

“Cures” others already fact-checked

See all 2

About colorectal cancer

Sources: NHS, NCI PDQ, MedlinePlus, NCI SEER

A cancer that starts in the colon or the rectum, parts of the large bowel. Signs include blood in your poo, changes in your usual bowel habits, tummy pain and losing weight without trying. Surgery is the most common treatment for colon cancer. You may also have chemotherapy, radiotherapy, targeted medicines or immunotherapy. The risk grows with age, and screening tests from about 45 can help find it early, when it may be easier to treat.

What is it?

Bowel cancer, also called colorectal cancer, is cancer anywhere in the large bowel: the colon or the rectum. The large bowel takes water from food and gets rid of waste. It is one of the most common cancers.

The risk grows with age, and you are more likely to get it if you are over 50. It is most often found in people aged 65 to 74. It is more likely if a close relative has had bowel cancer, or if you have an inherited condition such as Lynch syndrome or familial adenomatous polyposis (FAP). Crohn's disease or ulcerative colitis, bowel polyps (small growths), smoking and being overweight also raise the risk. Eating more fruit and vegetables, less red and processed meat, being active and drinking less alcohol can lower it.

The first signs

Bowel cancer may not cause signs at first.

  • changes in their poo that are not usual for them, such as softer poo, diarrhoea or constipation;
  • needing to poo more or less often than usual;
  • blood in their poo, which can look red or black, or bleeding from the bottom;
  • often feeling they need to poo, even just after going to the toilet;
  • tummy pain, a lump in the tummy or bloating;
  • losing weight without trying.

Feeling very tired or short of breath can be a sign of anaemia, which can be caused by bowel cancer. These signs often have other causes.

How doctors find out

If your family doctor thinks you could have bowel cancer, they send you to a specialist. The main test is a colonoscopy: a thin, bendy tube with a camera looks inside your bowel. It may be uncomfortable but should not hurt, and you are offered a sedative and painkillers. A small piece of the bowel lining (a biopsy) can be taken for testing. Stool tests that look for hidden blood are also used.

If it is cancer, CT, MRI or PET scans, blood tests and gene tests show how far it has spread and whether certain gene changes are involved. This helps your team choose the treatment. A specialist nurse is your main contact during and after treatment.

Current treatment

Surgery, often with chemotherapy or radiotherapy

Will it get worse?

It depends on how big the cancer is, whether it has spread, and your general health. About 23 in 100 bowel cancers have spread to other parts of the body when they are found. The outlook also depends on whether surgery can remove all of the tumour and whether the bowel is blocked.

Advanced bowel cancer can be hard to treat. Then treatment aims to slow the cancer, ease symptoms and help you live longer, and a palliative care team helps with symptoms and comfort. After treatment you have check-ups and tests. A blood test called CEA may be done to see whether the cancer has come back.

Medicines: what helps, and what to watch for

Chemotherapy is medicine that kills cancer cells. You may have it before surgery to shrink the cancer, after surgery to lower the chance of it coming back, instead of surgery, or when the cancer has spread. For advanced bowel cancer, targeted medicines can stop or slow its growth, and immunotherapy helps your immune system attack it. Biomarker tests can help predict how you will respond to certain targeted medicines.

Good to know:

  • Most people get some side effects of chemotherapy, but not all of them. Common ones are tiredness, feeling sick, a sore mouth, diarrhoea or constipation, hair loss that is usually temporary, and numbness or tingling in the hands or feet;
  • Your team explains the benefits and side effects of each treatment and helps you manage them.

Exercise and diet after surgery

If you have a stoma after surgery (see below), start with gentle activity, such as a short walk, when you feel ready. Once your bowel has settled, go back to your usual, balanced food.

Surgery and radiotherapy

Surgery is the most common treatment at every stage of colon cancer. The surgeon removes the cancer and some of the bowel around it. If the cancer is in a polyp, the polyp is often removed during a colonoscopy. The surgeon may then join the two healthy ends of the bowel back together. If the ends cannot be joined, a stoma (an opening on the outside of the body for waste to pass through) is made, and a bag collects the waste. It can be temporary or permanent.

Radiotherapy uses beams of radiation to kill cancer cells. It is used for cancer in the rectum and for cancer that has spread. If the cancer has spread to the liver, those parts may be removed by surgery. If you cannot have surgery, they may be destroyed with heat or by freezing.

Is there a cure?

Your outlook and treatment depend on the stage of the cancer. Bowel cancer found early, for example through screening, may be easier to treat. Advanced bowel cancer that has spread may be hard to treat and not possible to cure. New treatments are being tested in clinical trials.

See the 2,193 trials you can join

Median survival

About 29 to 30 months with first-line treatment, once it has spread

Measured in: Previously untreated metastatic colorectal cancer with KRAS wild-type tumours: the CALGB/SWOG 80405 trial (2,334 patients)

The figures behind it

NCI PDQ (health professional, colon), CALGB/SWOG 80405 (2,334 previously untreated patients with KRAS wild-type metastatic colorectal cancer): median overall survival 29.04 months with chemotherapy plus bevacizumab and 29.93 months with chemotherapy plus cetuximab; the difference was not statistically significant.